Insights into Critical Connections: Exploring Lipid Dynamics of ICU Patients In Tertiary Healthcare Settings
DOI:
https://doi.org/10.36283/ziun-pjmd15-1/021Keywords:
Critical illness, Cholesterol, Low Density Lipoprotein Cholesterol, High Density Lipoprotein Cholesterol, C-Reactive ProteinAbstract
Background: The critical illness involves dramatic changes in metabolic and inflammatory processes that have a long-lasting effect on lipid metabolism. The objective was to investigate the lipid dynamics among Intensive Care Unit (ICU) patients and establish relationship between repeated changes in lipid levels and clinical outcomes in patients with critical illness.
Methods: This prospective observational study, (June to November of 2024) was conducted at Department of Chemical Pathology, Combined Military Hospital Malir, Karachi, Pakistan. A total of 112 critically ill patients who were admitted to the ICU were enrolled. On day 1, day 3 and day 5 of ICU admission, Serum Total Cholesterol (TC), High-density lipoprotein Cholesterol (HDL-C), Low-density lipoprotein Cholesterol (LDL-C), C- Reactive protein (CRP) were measured. They were organized into two groups: Group A (increasing lipid trend) and Group B (decreasing lipid trend). Temporal changes and relationships with CRP levels and clinical outcomes were compared in SPSS version 27.
Results: Serum total cholesterol (p < 0.001), HDL-C (p = 0.002), and LDL-C (p < 0.001) showed a significant decrease between day 1 and day 5, but CRP showed a significant increase (p < 0.001). Group B patients (patients with a decreasing cholesterol trend) had a longer stay in the ICU (8.4 ± 3.2 days) and higher mortality rates (38.6) than Group A (5.9 ± 2.7 days, 14.3%). The reduction in LDL-C and HDL-C was greater in non-survivors than in survivors (p < 0.05).
Conclusion: Serial lipid measurements can be considered effective predictors of mortality and disease progression in patients with severe illness.
References
1. Lauwers C, De Bruyn L, Langouche L. Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targets. Intensive Care Med Exp. 2023 Nov 28;11(1):84. doi: 10.1186/s40635-023-00570-y.
2. Li S, Zhang W, Liu H. Association between lipid levels and all-cause and cause-specific mortality in critically ill patients. Sci Rep. 2023 Mar 29;13(1):5109. doi: 10.1038/s41598-023-32209-z.
3. Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 Aug 4;32(2):188-202.e5. doi: 10.1016/j.cmet.2020.06.016.
4. Wu J, Cyr A, Gruen DS, Lovelace TC, Benos PV, Das J,et al. Lipidomic signatures align with inflammatory patterns and outcomes in critical illness. Nat Commun. 2022 Nov 10;13(1):6789. doi: 10.1038/s41467-022-34420-4.
5. Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020 Jul 9;182(1):59-72.e15. doi: 10.1016/j.cell.2020.05.032.
6. Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Vanmarcke D, Debaveye Y, et al. Adrenocortical function during prolonged critical illness and beyond: a prospective observational study. Intensive Care Med. 2018 Oct;44(10):1720-1729. doi: 10.1007/s00134-018-5366-7.
7. Pradelli L, Klek S, Mayer K, Omar Alsaleh AJ, Rosenthal MD, Heller AR, et al. Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis. Crit Care. 2020 Nov 3;24(1):634. doi: 10.1186/s13054-020-03356-w.
8. Pradelli L, Mayer K, Klek S, Omar Alsaleh AJ, Clark RAC, Rosenthal MD, et al. ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. JPEN J Parenter Enteral Nutr. 2020 Jan;44(1):44-57. doi: 10.1002/jpen.1672.
9. Bhardwaj R, Agrawal U, Vashist P, Manna S. Determination of sample size for various study designs in medical research: A practical primer. J Family Med Prim Care. 2024 Jul;13(7):2555-2561. doi: 10.4103/jfmpc.jfmpc_1675_23.
10. Ko RE, Kang D, Cho J, Na SJ, Chung CR, Lim SY, et al. Korean Sepsis Alliance (KSA) investigators. Influence of gender on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2023 Jun 11;27(1):229. doi: 10.1186/s13054-023-04515-5.
11. Ismail AJ, Hassan WMNW, Nor MBM, Shukeri WFWM. The impact of age on mortality in the intensive care unit: a retrospective cohort study in Malaysia. Acute Crit Care. 2024 Aug;39(3):390-399. doi: 10.4266/acc.2024.00640.
12. Qin C, Minghan H, Ziwen Z, Yukun L. Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID-19 pneumonia patients. Food Sci Nutr. 2020 Oct 27;8(11):6144-6152. doi: 10.1002/fsn3.1907.
13. Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, et al. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020 Jun;107:154243. doi: 10.1016/j.metabol.2020.154243.
14. Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020 Nov;510:105-110. doi: 10.1016/j.cca.2020.07.015.
15. Wei X, Zeng W, Su J, Wan H, Yu X, Cao X, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020 May-Jun;14(3):297-304. doi: 10.1016/j.jacl.2020.04.008.
16. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4255. doi: 10.1093/eurheartj/ehz826.
17. Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, et al. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study. J Am Coll Cardiol. 2016 Nov 8;68(19):2073-2083. doi: 10.1016/j.jacc.2016.08.038.
18. Hofmaenner DA, Arina P, Kleyman A, Page Black L, Salomao R, Tanaka S, et al. Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis. Crit Care Explor. 2023 Feb 1;5(2):e0860. doi: 10.1097/CCE.0000000000000860.
19. Taylor R, Zhang C, George D, Kotecha S, Abdelghaffar M, Forster T, et al. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies. EBioMedicine. 2024 Feb;100:104981. doi: 10.1016/j.ebiom.2024.104981.
20. Lahoz C, Salinero-Fort MA, Cárdenas J, Rodríguez-Artalejo F, Díaz-Almiron M, Vich-Pérez P, et al. HDL-cholesterol concentration and risk of SARS-CoV-2 infection in people over 75 years of age: A cohort with half a million participants from the Community of Madrid. Clínica e Investigación en Arteriosclerosis (English Edition). 2022 May-June;34(3):113–9. doi: 10.1016/j.artere.2022.05.002.
21. Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, et al. Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group. Clin Nutr. 2018 Feb;37(1):1-18. doi: 10.1016/j.clnu.2017.08.032.
22. Al-Husinat L, Abu Hmaid A, Abbas H, Abuelsamen B, Albelbisi M, Haddad S, et al. Role of aspirin, beta-blocker, statins, and heparin therapy in septic patients under mechanical ventilation: a narrative review. Front Med (Lausanne). 2023 Jul 10;10:1143090. doi: 10.3389/fmed.2023.1143090.
23. Lauwers C, De Bruyn L, Langouche L. Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targets. Intensive Care Med Exp. 2023 Nov 28;11(1):84. doi: 10.1186/s40635-023-00570-y.
24. Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol. 2020 Nov 25;11:599853. doi: 10.3389/fimmu.2020.599853. PMID: 33324417; PMCID: PMC7724037.
25. Stevens J, Tezel O, Bonnefil V, Hapstack M, Atreya MR. Biological basis of critical illness subclasses: from the bedside to the bench and back again. Crit Care. 2024 May 29;28(1):186. doi: 10.1186/s13054-024-04959-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
